CRONIN JANE M.

Director Jane M. Cronin purchased 10,000 CLF shares at $10.56; holdings rose 68.9% to 24,522 shares

Jane M. Cronin, a director of Cleveland-Cliffs, executed an open-market purchase of 10,000 shares at $10.56 per share on 2025-02-28, increasing her holdings by 68.9% from 14,522 to 24,522 shares. The timing occurs with the stock trading at $10.84 current price, well below the 52-week high of $22.83 (-52.5%) and down 12.9% over the past 90 days, though up 5.8% in the past 30 days. Fundamentals remain challenged, with the company reporting a net loss of $-242,000,000.00 in the latest quarter and an annual revenue decline of -12.8%. Cronin's prior cross-ticker sell history shows a 50.00% well-timed rate (90-day), though with only 2 prior sells at an average 90-day return of -4.9%, providing limited predictive weight for assessing conviction in this specific CLF purchase.

SHW SVP Cronin sells 5,161 shares ($2.1M) at $398.06; continues pattern of poorly-timed exits.

Jane M. Cronin, SVP – Enterprise Finance, sold 5,161 shares of Sherwin Williams on 2024-11-25 at $398.06, reducing her position by 24.0%. This mirrors her prior SHW sale on 2024-07-30: both trades have been followed by stock appreciation (30-day +2.8% and 90-day +3.6% after the July sale; current price $393.96 is -1.4% from the 52-week high of $399.71). Across her cross-ticker open-market trading history, 0 of her prior sells were well-timed at the 90-day mark, with an average 90-day return of +3.6% after her sales — indicating the stock typically rose after she exited. At SHW specifically, the prior 2024-07-30 sale has registered 90-day gains, continuing a pattern of exits that have preceded rallies rather than declined markets.

SVP Jane M. Cronin sold 9,320 SHW shares at $350.75 on 2024-07-30; holdings reduced 35.7% to 16,816 shares

Jane M. Cronin, SVP of Enterprise Finance at Sherwin Williams, sold 9,320 shares on 2024-07-30 at $350.75, representing a 35.7% reduction in her holdings from 26,136 to 16,816 shares, for total proceeds of $3,268,990.00. The transaction occurred near the 52-week high of $352.55, with the stock having gained 18.9% over the prior 30 days and 12.6% over 90 days. At a P/E of 35.18, the stock trades at an elevated multiple relative to historical context. The magnitude of the position reduction—more than one-third of holdings—represents a substantial decrease in her direct equity stake in the company.